Shanghai Haixin Group Co EBITDA TCAC 5A

Que fait Shanghai Haixin Group Co ? Shanghai Haixin Group Co., Ltd. generates revenue through its Textile segment, which produces and sells plush fabrics and clothing, and its Pharmaceutical segment, which manufactures and sells pharmaceutical products. The company also earns income from financial investment business and industrial plant rental management, operating across domestic and overseas markets. Its primary customers include businesses purchasing textiles for clothing production and pharmaceutical buyers seeking medical products, while the financial investment segment attracts institutional investors. The firm's domestic market focus complements its overseas sales channels for both textile and pharmaceutical goods. The Textile segment's plush fabrics and clothing are sold to manufacturers and retailers, while the Pharmaceutical segment's products target healthcare providers and distributors. Financial investments provide passive income streams, and industrial plant rentals contribute to operational revenue. The company's dual-segment approach ensures diversified income sources from both product manufacturing and asset management. Shanghai Haixin's business model relies on the consistent demand for plush fabrics in the apparel industry and pharmaceutical products in healthcare. The financial investment segment leverages capital to generate returns, and industrial plant rentals utilize underused facilities for additional revenue. These segments collectively serve domestic and international clients without relying on external partnerships or third-party services. Shanghai Haixin Group Co est l'une des entreprises les plus populaires sur Eulerpool.